162 results on '"Nagy, Magdolna"'
Search Results
2. Current and potentially novel antithrombotic treatment in acute ischemic stroke
3. The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-associated vasculitis
4. Association of primary and secondary hemostasis biomarkers with acute ischemic stroke outcome in patients undergoing thrombectomy, with or without thrombolytics: post hoc analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands-NO IV
5. Platelet glycoprotein V spatio-temporally controls fibrin formation
6. Predictive value for increased activated factor XI activity in acute venous thromboembolism
7. Antagonistic Roles of Human Platelet Integrin αIIbβ3 and Chemokines in Regulating Neutrophil Activation and Fate on Arterial Thrombi Under Flow
8. Inhibition of platelet adhesion, thrombus formation, and fibrin formation by a potent αIIbβ3 integrin inhibitor from ticks
9. Complementary roles of platelet αIIbβ3 integrin, phosphatidylserine exposure and cytoskeletal rearrangement in the release of extracellular vesicles
10. Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions
11. Evaluation of the analytical performance of the PC100 platelet counter
12. Platelet biology and function: plaque erosion vs. rupture
13. Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection
14. Native, Intact Glucagon-Like Peptide-1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions
15. Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19
16. Platelet biology and function: plaque erosion vs. rupture.
17. Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19
18. Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19
19. Defective Zn2+ homeostasis in mouse and human platelets with α- and δ-storage pool diseases
20. Antagonistic Roles of Human Platelet Integrin aiibpS and Chemokines in Regulating Neutrophil Activation and Fate on Arterial Thrombi Under Flow.
21. Integrating Mechanisms in Thrombotic Peripheral Arterial Disease
22. Differential Fibrinolysis Profile in COVID-19 Patients Dependent on Immunosuppressive Treatment Regimen: A Nested Case-Control Study
23. Thrombin Generation Is Differentially Affected By Anticoagulants in Patients with Acute Lymphoblastic Leukemia - an Ex-Vivo Study
24. Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trial
25. Unraveling the role of the homoarginine residue in antiplatelet drug eptifibatide in binding to the αIIbβ3 integrin receptor
26. What to expect from drug targeting factor XI?
27. Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort
28. MicroRNA-26b Attenuates Platelet Adhesion and Aggregation in Mice
29. The Composition and Physical Properties of Clots in COVID-19 Pathology
30. Antiplatelet Therapy in Patients With COVID-19—More Is Less?
31. ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin‐6
32. természetes gyeptípusok módosulása a használat és művelés hatására a Baróti hegységben – Kovászna megye
33. Predictive Value for Increased Factor XIa and Plasma Kallikrein Activity in Acute Venous Thromboembolism
34. Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System
35. Hogyan látják a múzeumok a felsőoktatással való kapcsolatot és a továbbfejlesztés lehetőségeit?
36. Inhibition of Phosphodiesterase 3A by Cilostazol Dampens Proinflammatory Platelet Functions
37. Platelet activation by charged ligands and nanoparticles: platelet glycoprotein receptors as pattern recognition receptors
38. Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease
39. Platelet activation by charged ligands and nanoparticles:platelet glycoprotein receptors as pattern recognition receptors
40. Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability
41. Comparison of the GPVI inhibitors losartan and honokiol
42. Platelet function is modified by common sequence variation in megakaryocyte super enhancers
43. The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice
44. Comparative Analysis of Microfluidics Thrombus Formation in Multiple Genetically Modified Mice: Link to Thrombosis and Hemostasis
45. Comparison of the GPVI inhibitors losartan and honokiol
46. Store-operated calcium entry in thrombosis and thrombo-inflammation
47. High-throughput elucidation of thrombus formation reveals sources of platelet function variability
48. Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets
49. Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients
50. Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.